News & Events2024-11-12T13:54:15+00:00
News
Home»Company»News & Events

News & Events

Your source for the latest updates, breakthroughs, and insights in drug development and manufacturing. Explore our featured stories, press releases, and event announcements to stay informed about our innovations and contributions to drug development and manufacturing advancements.

3008, 2022

First allogeneic cell therapy candidate engineered to target cd19 for b-cell malignancies receives IND clearance, will proceed to clinical trials

August 30th, 2022|Gene & Cell Therapy Testing, News|

Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, announced today that the company has been notified by the U.S. Food and Drug Administration (FDA) that the Company’s ELiPSE-1 clinical study may proceed [...]

2308, 2022

FDA approves the first gene therapy for people with beta-thalassemia who require regular red blood cell transfusions

August 23rd, 2022|Gene & Cell Therapy Testing, News|

bluebird bio has announced the the U.S. Food and Drug Administration (FDA) has approved ZYNTEGLO® (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who [...]

208, 2022

ARM and NIIMBL Release Project A-Cell to Bring Quality by Design Principles to Cell-Based Therapy Manufacturing

August 2nd, 2022|CAR-T & Other Cell Therapy Testing, Gene & Cell Therapy Testing|

Effort to address challenges to the manufacturing scale-up of cell-based therapies follows release of Project A-Gene for gene therapy in 2021 The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released Project [...]

2007, 2022

New next-gen sequencing technique could accelerate and improve mRNA therapies by quantifying how LNPs deliver mRNA into cells

July 20th, 2022|GLP Sequencing, mRNA therapeutics, Next-Gen Sequencing|

Therapeutics based on messenger RNA, or mRNA, can potentially treat a wide range of maladies, including cancer, genetic diseases, and as the world has learned in recent years, deadly viruses. To work, these drugs must be delivered directly to [...]

1207, 2022

New method combines a T-cell “barcode” with single-cell RNA sequencing to enhance CAR T–cell therapy

July 12th, 2022|GLP Sequencing, Next-Gen Sequencing|

Scientists at St. Jude Children’s Research Hospital have developed a method that may be able to improve CAR T-cell therapies by identifying the early cells that become effective at killing cancer. St. Jude Children’s Research Hospital scientists have demonstrated that the long-term [...]

Go to Top